Total Serum IgG Is a Poor Surrogate for Pneumococcal Protection Following Hematopoietic Stem Cell Transplantation in Pediatric Sickle Cell Disease

Background Children with sickle cell disease (SCD) have functional asplenia and a higher risk of invasive pneumococcal disease. While allogeneic hematopoietic stem cell transplantation (HSCT) is curative, post‐transplant immune reconstitution is heterogeneous. Total serum immunoglobulin G (IgG) is widely used to gauge humoral recovery yet may not reflect pneumococcal serotype‐specific seroprotection. Methods We performed a single‐center retrospective cohort study of pediatric patients with SCD who underwent myeloablative matched sibling donor HSCT at Texas Children's Hospital between 2005 and 2024 and obtained pneumococcal serotype‐specific antibody titers at approximately 1 year. Seroprotection was defined as an antibody concentration ≥1.3 µg/mL in ≥70% of 14 tested serotypes. Longitudinal total IgG, IgA, IgM, tetanus titers, and lymphocyte subsets (CD3 + , CD4 + , CD8 + , CD19 + ) were analyzed. Receiver operating characteristic (ROC) analysis and penalized multivariable logistic regression were performed ( n = 51). Results Of 51 patients, 32 (62.7%) achieved pneumococcal serotype‐specific protection at approximately 1 year. Total IgG correlated weakly with protection at all time points ( r = 0.28–0.38). Day +365 total IgG did not differ between protected and unprotected patients ( p = 0.134); at commonly used thresholds between 400 and 600 mg/dL, sensitivity was 97%, but specificity was 0%, and all unprotected patients exceeded 600 mg/dL. Day +365 IgG showed limited discrimination (AUC 0.63). Broad quantitative lymphocyte subsets were also not significantly correlated with the proportion of protective pneumococcal serotypes. No invasive pneumococcal disease occurred during follow‐up. Conclusions Normal total serum IgG does not reliably identify pneumococcal serotype‐specific seroprotection after HSCT in pediatric SCD. Serotype‐specific antibody assessment provides information not captured by total IgG alone.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2026-11-18
DOI
https://doi.org/10.1002/1545-5017.70831
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Total Serum IgG Is a Poor Surrogate for Pneumococcal Protection Following Hematopoietic Stem Cell Transplantation in Pediatric Sickle Cell Disease

Baheyeldin M. Salem, Erin Doherty, Anil P. George, Helen Elisabeth Heslop et al.
2 links
Pediatric Blood & Cancer
Hemoglobinopathies and Related Disorders
article

Total Serum IgG Is a Poor Surrogate for Pneumococcal Protection Following Hematopoietic Stem Cell Transplantation in Pediatric Sickle Cell Disease

Baheyeldin M. Salem, Erin Doherty, Anil P. George, Helen Elisabeth Heslop, Caridad A. Martinez, H. Tinsley, Khaled Yassine, Bilal A. Omer, Erin Morales, David Steffin, Robert Allen Krance, Alexander I. Ngwube, Duc Tan Nguyen, Megha Thakkar, John A. Craddock, Josaura Fernandez, Kendall Oh, Alonzo Needum, Gabriela Llaurador
article en

Abstract

Background Children with sickle cell disease (SCD) have functional asplenia and a higher risk of invasive pneumococcal disease. While allogeneic hematopoietic stem cell transplantation (HSCT) is curative, post‐transplant immune reconstitution is heterogeneous. Total serum immunoglobulin G (IgG) is widely used to gauge humoral recovery yet may not reflect pneumococcal serotype‐specific seroprotection. Methods We performed a single‐center retrospective cohort study of pediatric patients with SCD who underwent myeloablative matched sibling donor HSCT at Texas Children's Hospital between 2005 and 2024 and obtained pneumococcal serotype‐specific antibody titers at approximately 1 year. Seroprotection was defined as an antibody concentration ≥1.3 µg/mL in ≥70% of 14 tested serotypes. Longitudinal total IgG, IgA, IgM, tetanus titers, and lymphocyte subsets (CD3 + , CD4 + , CD8 + , CD19 + ) were analyzed. Receiver operating characteristic (ROC) analysis and penalized multivariable logistic regression were performed ( n = 51). Results Of 51 patients, 32 (62.7%) achieved pneumococcal serotype‐specific protection at approximately 1 year. Total IgG correlated weakly with protection at all time points ( r = 0.28–0.38). Day +365 total IgG did not differ between protected and unprotected patients ( p = 0.134); at commonly used thresholds between 400 and 600 mg/dL, sensitivity was 97%, but specificity was 0%, and all unprotected patients exceeded 600 mg/dL. Day +365 IgG showed limited discrimination (AUC 0.63). Broad quantitative lymphocyte subsets were also not significantly correlated with the proportion of protective pneumococcal serotypes. No invasive pneumococcal disease occurred during follow‐up. Conclusions Normal total serum IgG does not reliably identify pneumococcal serotype‐specific seroprotection after HSCT in pediatric SCD. Serotype‐specific antibody assessment provides information not captured by total IgG alone.

Pediatric Blood & Cancer
Baylor College of Medicine (US), Texas Children's Hospital (US), Children's Cancer Center (US)
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon